NORA NOKES: Open Payments
NPI 1497369318 · GREAT BEND, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$204 in 10 payments from 7 companies in 2025. Trend: 2023 $61 · 2024 $166 · 2025 $204
Food & beverage: $204
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $55 |
| Novo Nordisk Inc | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| ABBVIE INC. | 1 | $23 |
| Seqirus USA Inc | 1 | $20 |
| Dexcom, Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: REXULTI, FARXIGA, Ozempic, QULIPTA, Flucelvax, Dexcom G6 Transmitter, SHINGRIX, Rybelsus.
Industry payments across KS — which companies pay providers there.
